Paul F. Truex
2016
In 2016, Paul F. Truex earned a total compensation of $1.4M as Former CEO and Director at Anthera Pharmaceuticals, a 55% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $193,554 |
|---|---|
| Option Awards | $821,888 |
| Salary | $432,765 |
| Total | $1,448,207 |
Truex received $821.9K in option awards, accounting for 57% of the total pay in 2016.
Truex also received $193.6K in non-equity incentive plan and $432.8K in salary.
Rankings
In 2016, Paul F. Truex's compensation ranked 6,426th out of 14,075 executives tracked by ExecPay. In other words, Truex earned more than 54.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,426 out of 14,075 | 54th |
Division Manufacturing | 2,372 out of 5,489 | 57th |
Major group Chemicals And Allied Products | 777 out of 1,895 | 59th |
Industry group Drugs | 593 out of 1,538 | 61st |
Industry Pharmaceutical Preparations | 469 out of 1,176 | 60th |
Source: SEC filing on March 16, 2017.
Truex's colleagues
We found five more compensation records of executives who worked with Paul F. Truex at Anthera Pharmaceuticals in 2016.
2016
Craig Thompson
Anthera Pharmaceuticals
Chief Executive Officer
2016
William Shanahan
Anthera Pharmaceuticals
Chief Medical Officer
2016
Chuck Olson
Anthera Pharmaceuticals
Chief Technology Officer
2016
Klara Dickinson-Eason
Anthera Pharmaceuticals
SVP, Chief Regulatory Office
2016
May Liu
Anthera Pharmaceuticals